Search
Search results
-
Public Health Insurance is Near a Financial Tipping Point
Appeared in the Winnipeg Free Press, 03 October 2006 Recent research illustrates the cold, hard economic reality that we cannot rely on public funds alone to pay for the kind of modern health system we all want. We are near the limit of what taxpayers can ...
-
Paying More, Getting Less 2006
This study is The Fraser Institute's third annual report on the financial sustainability of provincial public health insurance. Every year the data are updated and new projections generated. This year's analysis again uses the most recent five ...
-
Prescription Piracy: The Black Market in Foreign Drugs Will Not Reduce U.S. Health Care Costs
This is a chapter from the book What States Can Do to Reform Health Care: A Free-Market Primer. Seven leading scholars contributed chapters to this book, which focuses on Medicaid, health insurance, hospital certificate-of-need laws, malpractice liability ...
-
Price Controls, Patents, and Cross-Border Internet Pharmacies: Risks to Canada's Drug Supply and International Trading Relations
This study measures and analyzes the export trade in prescription drugs between Canadian Internet pharmacies and American consumers. It does not directly measure the additional value of the cross-border drug trade that also occurs between physical brick ...
-
Public Health Care on Path to Bankruptcy
For each of the past five years, public spending on health care in every province has grown faster on average than total revenues from all sources including federal transfers. Nationally, public health spending grew 8 percent annually, compared to 3.9 ...
-
Paying More, Getting Less 2005
If recent trends in the annual growth rates for provincial public health-care expenditure and total provincial government revenue from all sources are used to project future growth in these measures, it becomes evident that health-care financing as it is ...
-
Universal Drug Benefits for Seniors: Unnecessary, Unsustainable, and Unfair
Provincial governments in Canada have special, publicly funded, programs that reimburse seniors for their spending on prescription drugs. The United States recently passed federal legislation, the Medicare Prescription Drug, Improvement, and Modernization ...
-
Seniors and Drug Prices in Canada and the United States, 2005
This report compares Canada-US price differences for the prescription drugs that are most important to Canadian seniors (aged 60 and older). This report analyzes prices for the drugs most commonly prescribed to Canadian seniors in 2007, and compares ...
-
Canada's Drug Price Paradox: The Unexpected Losses Caused by Government Interference in Pharmaceutical Markets
This study shows that Canadians pay much more than they should for generic drugs and that this is because of the very government policies that were supposed to make prescription medicines cheaper in the first place. This study also finds that price ...
-
Generic Drugopoly: Why Non-patented Prescription Drugs Cost More in Canada than in the United States and Europe
Studies comparing international prices of prescription pharmaceuticals have found that Canadian prices are close to the international median price for patented drugs but higher for non-patented single-source (usually brand-name) drugs, and also higher for ...